(Q37856393)

24 August 2017

1 reference

title

Hepatitis C virus entry and the tetraspanin CD81. (English)

1 reference

24 August 2017

1 reference

1 reference

3

1 reference

24 August 2017

Michelle J Farquhar

1

1 reference

PubMed ID

21428934

24 August 2017

Helen J Harris

series ordinal

2

1 reference

24 August 2017

1 April 2011

1 reference

Biochemical Society Transactions

24 August 2017

1 reference

24 August 2017

39

1 reference

24 August 2017

2

1 reference

24 August 2017

532-536

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

24 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Structure-function analysis of hepatitis C virus envelope-CD81 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

CD81-Dependent Binding of Hepatitis C Virus E1E2 Heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

CD81 is an entry coreceptor for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Diverse CD81 Proteins Support Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Association of hepatitis C virus in human sera with beta-lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Correlation of the Tight Junction-like Distribution of Claudin-1 to the Cellular Tropism of Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Claudin association with CD81 defines hepatitis C virus entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Hepatitis C virus receptor expression in normal and diseased liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Single-molecule analysis of CD9 dynamics and partitioning reveals multiple modes of interaction in the tetraspanin web.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Novel Function of CD81 in Controlling Hepatitis C Virus Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Association of hepatitis C virus envelope proteins with exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Hepatitis C virus infection of neuroepithelioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0390532

21 January 2018

Identifiers

DOI

10.1042/BST0390532

1 reference

24 August 2017

1 reference

PubMed ID

21428934